If you or a loved one have taken Actos, medical professionals advise monitoring for symptoms of bladder cancer, which include:
Research has suggested that long-term use of Actos may be associated with a higher risk of developing bladder cancer.
In 2011, the FDA issued a safety communication warning about these risks. Around the same time, countries like France and Germany suspended or restricted the use of the drug. ACTOS CANCER
Actos is a brand-name prescription drug (generic name: ) manufactured by Takeda Pharmaceuticals . It belongs to a class of drugs called thiazolidinediones, designed to help adults with type 2 diabetes manage their blood sugar levels by improving insulin sensitivity. 2. The Connection to Bladder Cancer
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more highlights of prescribing information - Takeda If you or a loved one have taken
Studies indicated that the risk increased with higher cumulative doses and longer duration of use (specifically more than 12 months).
, such as needing to urinate more frequently or urgently. Pain during urination (dysuria). Pain in the lower back or pelvic region . 4. Legal Status and Claims Actos is a brand-name prescription drug (generic name:
In 2015, Takeda Pharmaceuticals agreed to a massive $2.37 billion settlement to resolve approximately 9,000 bladder cancer claims in the U.S..